Meropenem 1g IV Infusion Bag Premixed from Japan
A ready-to-use premixed intravenous infusion bag containing 1g of meropenem in saline solution for direct administration in treating complicated intra-abdominal infections. Classified under HTS 3004.20.00.76 due to its meropenem content in a measured dose form for therapeutic prophylactic uses. It qualifies as a mixed product per chapter notes when dissolved for administration.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Include detailed formulation certificates confirming meropenem concentration and sterility testing results
• Use validated temperature-controlled shipping to prevent degradation, as meropenem is sensitive to heat
• Label shipments clearly as pharmaceutical goods to expedite customs and avoid quarantine delays